Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
Acta Obstetricia Et Gynecologica Scandinavica|June 7, 2003
Correlation between estrogen receptor alpha expression, collagen content and stiffness in human uterine arteriesMarie-Louise Lydrup, Mårten FernöActa Oncologica (Stockholm, Sweden)|April 1, 2003
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessmentGunilla Chebil, Pär-Ola Bendahl, Mårten Fernö, et al.BMC Molecular Biology|May 24, 2007
RNA quality in frozen breast cancer samples and the influence on gene expression analysis--a comparison of three evaluation methods using microcapillary electrophoresis tracesCarina Strand, Johan Enell, Ingrid Hedenfalk, et al.Histopathology|June 15, 2011
Analysis of sentinel node biopsy - a single-institution experience supporting the use of serial sectioning and immunohistochemistry for detection of micrometastases by comparing four different histopathological laboratory protocolsDorthe Grabau, Lisa Ryden, Mårten Fernö, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 21, 2003
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelinesBo Baldetorp, Pär-Ola Bendahl, Mårten Fernö, et al.Gynecologic Oncology|October 8, 2003
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancerChrister Borgfeldt, Pär-Ola Bendahl, Mårten Fernö, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilersPatrik Edén, Cecilia Ritz, Carsten Rose, et al.Cell Cycle (Georgetown, Tex.)|March 2, 2011
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifenSophie Lehn, Mårten Fernö, Karin Jirström, et al.BMC Cancer|November 27, 2013
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trialAnna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl, et al.World Journal of Surgery|March 10, 2010
Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl, et al.Pageof 13